Trial Profile
To compare the risk of stroke by severity and mortality post stroke between rivaroxaban and warfarin treated patients with non-valvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association